Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy

NCT01128959 Phase 3 COMPLETED Results posted

The purpose of this study is to assess the safety and tolerability of intravenous (IV) carbamazepine (CBZ) administered as multiple 15 minute infusions and a single 5 minute infusion to adult patients with epilepsy on stable higher doses of oral CBZ.

Details

Lead sponsor	Lundbeck LLC
Phase	Phase 3
Status	COMPLETED
Enrolment	108
Start date	2010-06
Completion	2013-01

Conditions

• Epilepsy

Interventions

• Intravenous Carbamazepine (IV CBZ)

Primary outcomes

• Adverse Events — Baseline to after last iv dose on day 4

Countries

United States